Ifp Advisors, Inc Aurinia Pharmaceuticals Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 271,132 shares of AUPH stock, worth $2.11 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
271,132
Previous 207,025
30.97%
Holding current value
$2.11 Million
Previous $1.52 Million
60.45%
% of portfolio
0.08%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding AUPH
# of Institutions
230Shares Held
59MCall Options Held
1MPut Options Held
1.61M-
Black Rock Inc. New York, NY9.27MShares$72.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$65.7 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$49.9 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$30.9 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$22.7 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.11B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...